Patents by Inventor Ditte Maria Karpf

Ditte Maria Karpf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds Suitable for Treatment of Haemophilia
    Publication number: 20180179262
    Abstract: The present invention relates to VWF compounds as well as compositions suitable for treatment of blood clotting diseases.
    Type: Application
    Filed: February 8, 2018
    Publication date: June 28, 2018
    Inventors: Gert Bolt, Ditte Maria Karpf, Frederik Rode, Jesper Haaning, Kirstine Roepstorff, Lars Thim, Maj Petersen, Marianne Hjortnaes Kjalke, Ole Hvilsted Olsen, Jens Jacob Hansen
  • Compounds Suitable for Treatment of Haemophilia
    Publication number: 20160318991
    Abstract: The present invention relates to VWF compounds as well as compositions suitable for treatment of blood clotting diseases.
    Type: Application
    Filed: May 4, 2016
    Publication date: November 3, 2016
    Inventors: Gert Bolt, Ditte Maria Karpf, Frederik Rode, Jesper Haaning, Kirstine Roepstorff, Lars Thim, Maj Petersen, Marianne Kjalke, Ole Hvilsted Olsen, Jens Jacob Hansen
  • Compounds Suitable for Treatment of Haemophilia
    Publication number: 20160207977
    Abstract: The present invention relates to Von Willebrand (VWF) compounds as well as compositions suitable for treatment of blood clotting diseases. The present invention also relates to pharmaceutical compositions, freeze-dried or liquid, comprising (i) a Factor VIII molecule and (ii) a VWF compound.
    Type: Application
    Filed: June 10, 2014
    Publication date: July 21, 2016
    Inventors: Ole Hvilsted Olsen, Marianne Hjortnaes Kjalke, Maj Petersen, Lars Thim, Kirstine Roepstorff, Jens Jacob Hansen, Jesper Haaning, Frederik Rode, Ditte Maria Karpf, Christian Rischel, Gert Bolt
  • Compounds suitable for treatment of haemophilia
    Patent number: 9125890
    Abstract: The present invention relates to Von Willebrand (VWF) compounds as well as compositions suitable for treatment of blood clotting diseases. The present invention also relates to pharmaceutical compositions, freeze-dried or liquid, comprising (i) a Factor VIII molecule and (ii) a VWF compound.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: September 8, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Gert Bolt, Ditte Maria Karpf, Frederik Rode, Jesper Haaning, Kirstine Roepstorff, Lars Thim, Maj Petersen, Marianne Kjalke, Ole Hvilsted Olsen, Jens Jacob Hansen, Christian Rischel
  • Modification of Factor VIII
    Publication number: 20110306551
    Abstract: A Factor VIII derivative of formula (I): wherein: B represents C2 to C10 alkylene; m represents 0 or an integer from 1 to 19, n represents an integer from 1 to 20, and the sum of m and n is from 1 to 20; P represents a mono or polyradical of Factor VIII obtained by removing m+n carbamoyl groups from the side chains of glutamine residues in Factor VIII; and M represents a moiety (M1) that increases the plasma half-life of the Factor VIII derivative or a reporter moiety (M2); or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 18, 2010
    Publication date: December 15, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Magali Zundel, Bernd Peschke, Ditte Maria Karpf, Kjeld Madsen